Large-scale pathways-based association study in amyotrophic lateral sclerosis

Area of Science:

• Neurogenetics
• Neurodegenerative Diseases
• Genomic Association Studies

Background:

• Sporadic amyotrophic lateral sclerosis (ALS) arises from complex genetic and environmental factors.
• Previous genetic studies for ALS yielded inconsistent findings due to small sample sizes and limited gene investigation.
• Defects in axonal transport, vesicle trafficking, and xenobiotic metabolism are implicated in motor neuron death.

Purpose of the Study:

• To investigate the role of common genetic variations in specific biological pathways in sporadic ALS susceptibility.
• To conduct a pathway-based candidate gene association study with replication.
• To assess the reliability of whole genome amplified DNA for large-scale genetic association studies.

Main Methods:

• A case-control association study genotyped 1277 SNPs in 134 genes in 822 British ALS patients and 872 controls.
• Whole genome amplified DNA was used for genotyping.
• Replication analysis involved genotyping 19 selected SNPs in 580 German ALS patients and 361 controls.

Main Results:

• No strong evidence of association was found between common variations in the investigated pathways and sporadic ALS in the discovery sample.
• None of the suggestive associations from the initial screen were replicated in the German sample.
• Whole genome amplified DNA demonstrated reliable genotyping efficiency and quality for large-scale studies.

Conclusions:

• Common genetic variations within the studied pathways are unlikely to be major contributors to sporadic ALS susceptibility.
• The findings exclude variants with moderate effect sizes in these pathways.
• Whole genome amplified DNA is a reliable method for large-scale genetic studies in diseases like ALS with limited sample availability.